Rekombinanter HHV8 Antikörper

Produktnummer ABIN6937459

Produktdetails anti-HHV8 Antikörper

Target: HHV8 (Herpes Virus Type 8 (HHV8))

Antikörpertyp: Recombinant Antibody

Reaktivität: Herpes Simplex Virus (HSV)

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser HHV8 Antikörper ist unkonjugiert

Applikation: ELISA, Coating (Coat)

Aufreinigung: Purified by Protein A/G

Immunogen: Recombinant protein corresponding to the latent nuclear antigen 1 molecule of HHV8

Klon: HHV8-3606

Isotyp: IgG1 kappa

Anwendungsinformationen

Applikationshinweise:

Positive Control: Herpes simplex type 1 (HSV-1) extract or infected cells. Tissue.

Known Application: ELISA (For coating use Ab at 1-5 μg/mL, order Ab without BSA), Optimal dilution for a specific application should be determined.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Buffer: 10 mM PBS without BSA and without Azide.

Konservierungsmittel: Azide free

Lagerung: 4 °C,-80 °C

Informationen zur Lagerung: Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months.

Haltbarkeit: 24 months

Details zu HHV8

Target: HHV8 (Herpes Virus Type 8 (HHV8))

Andere Bezeichnung: Human Herpes Virus 8 (HHV8) (HHV8 Produkte)

Substanzklasse: Virus

Hintergrund: HHV 8 encodes a latent nuclear antigen (LNA), which is the product of the viral gene orf 73. LNA is capable of forming a complex with retinoblastoma susceptibility gene product, which may be related to its oncogenic activity. HHV8 is associated with three different diseases observed in AIDS patients, kaposi's sarcoma, primary effusion lymphoma (which is a rare type of non-Hodgkin lymphoma affecting the body cavities) and multicentric Castleman's disease. HHV 8 is the likely etiological agent of Kaposis sarcoma.